Pancreatic cancer: Advances and challenges

Halbrook, Christopher J., Lyssiotis, Costas A., Pasca di Magliano, Marina, Maitra, Anirban·2023·Cell

Cited by (999)

Items 501–600 of 999

  1. Targeting Kinase Suppressor of Ras 1 (KSR1) for Cancer Therapy
    Hyuk Moon, Hyunjung Park, Soyun Lee, S.-H. Lee, Simon Weonsang Ro · 2025 · Pharmaceutics
  2. Targeting Mutual Dependence of Phosphatidylinositol-3-Kinase α/δ and Small Ubiquitin-Like Modifier Signaling in Pancreatic Cancer
    Hazal Köse, Christian Schneeweis, Philipp Putze, Constanza Tapia Contreras, Laura Ferreiro, Leonie Witte, Ilaria Deidda, Frederik Herzberg, Sophie Ebert, Juraj Jakubík et al. · 2025 · Gastroenterology
  3. Application and prospects of ultrasound combined with immunotherapy in cancer treatment of intensive care
    Yaping Wang, Cong Liu, Riley Lyu, Yan Zhang · 2025 · Frontiers in Immunology
  4. Harnessing cuproptosis for pancreatic cancer therapy: From molecular insights to clinical prospects
    Ali Darzi, Siavash Boroumandi, Pouriya Khajegi, Mohammadreza Dehdashti, Pedram Abdali, Mohammad Moein Amerinia, Fatemeh Kheirkhah, Mohammad Mahdi Ajalli, Mahla Shokouhfar · 2025 · Biomedicine & Pharmacotherapy
  5. ENO1-mediated deoxycytidine synthesis and gemcitabine resistance by stabilizing RRM2 in pancreatic cancer
    Yongning Li, Hao Wang, L Chen, Yanyu Gong, Dijie Zheng, Futang Li, Changhao Wu, Zhiwei He, Chao Yu · 2025 · Cell Death and Disease
  6. Antimetastatic effects of MRTX1133 KRAS G12D specific inhibitor in a liver metastatic model of pancreatic ductal adenocarcinoma
    Krisztina Andrea Szigeti, Marcell Baranyi, Sára Eszter Surguta, Balázs Hegedűs, Violetta Piurkó, József Tóvári, József Tı́már · 2026 · Scientific Reports
  7. Highly Expressed Fatty Acid‐Binding Protein 6 Mediates Lipid Metabolism Remodeling in Tumor Cells via Intracellular Bile Acid Transport to Promote Pancreatic Cancer Metastasis
    Jiepeng Jia, Chao Bai, Wen Zhang, Jiale Xu, Tao Hu · 2026 · Molecular Carcinogenesis
  8. Downregulation of NFIA facilitates glycolysis, histone lactylation, and activation of the FN1–integrin α5β1 pathway in pancreatic cancer
    Xi Zhang, Yang Liu, Xiaoming Liu, Juan Tan, Lehong Yuan, Weijie Wu, Xiaoyan Li, Pan Xi, Guoyin Li, Zewen Song · 2026 · APOPTOSIS
  9. TIGIT disruption rescues the antitumor activity of low avidity TCR-engineered T cells by increasing TCR signal strength
    Martina Spiga, Alessia Potenza, Zulma Irene Magnani, Stefano Beretta, Barbara Camisa, Laura Conte, Alessia Airaghi, Neda Mohammadi, Laura Perani, Claudio Doglioni et al. · 2026 · Nature Communications
  10. PanMETAI - a high performance tabular foundation model for accurate pancreatic cancer diagnosis via NMR metabolomics
    Danni Wu, Jin Jen, Erickson Fajiculay, Min‐Fen Hsu, Ming‐Chu Chang, Jen-Chen Yeh, Karen Sargsyan, Juozas Kupčinskas, Jurgita Skiecevičienė, Rūta Steponaitienė et al. · 2026 · Nature Communications
  11. Discovery of a Novel Dual-Targeting KRAS G12D /HDAC Peptide Inhibitor for the Treatment of Pancreatic Cancer
    Qiaoxuan Zhang, Yifei Geng, Haitao Chen, Jiaping Ni, Lixia Guan, Dongqing Zhai, Yuting Wang, Shengtao Xu, Miaomiao Niu, Lufeng Zheng et al. · 2026 · Journal of Medicinal Chemistry
  12. Cancer in 4D: toward Spatiotemporal Hallmark Ecosystems
    Mustafa Sibai, Martin Zacharias, Nicholas McGranahan, Mariam Jamal‐Hanjani, Eduard Porta‐Pardo · 2026 · Trends in cancer
  13. Autophagy related RHEB-CSF1R complex promotes tumor metastasis via advancing phosphorylation levels of PI3K, AKT, mTOR in pancreatic cancer
    Qianxi Deng, Kun Yang, Jin He, Jun-Feng Li, Xiao-Qing Li, Long Zou, Yi-Ming Li, Shu-Man Xu, Zheng Jiang, Lin-Ju Wu · 2026 · World Journal of Gastroenterology
  14. A sulfated pectin polysaccharide from Chrysanthemum morifolium induces ferroptosis in pancreatic cancer by stabilizing TFRC
    Zixuan Wang, Youning Jiang, Yilin Wang, Shengjie Wu, ShiyingZhang, Can Jin, He Fei, Kan Ding · 2026 · Carbohydrate Polymers
  15. Reconstructing tumor tissues in 3D: From organoids to bioengineered niches
    Verena Kast, Fatemeh Navaee, Majid Halvaei, Stefan Liebau, Ninel Azoitei, Markus Breunig, Peter Loskill, Alexander Kleger · 2026 · Cell stem cell
  16. Single-cell spatial transcriptional profiling of pancreatic ductal adenocarcinoma uncovers key immune-modulating and pro-metastatic mechanisms
    Jing Zhou, Guodong Shi, Shangnan Dai, Shitao Wu, Fangze Qian, Zehao Wu, Jiaxuan Zhang, Yefan Yang, Bin Xiao, Zipeng Lu et al. · 2026 · Cancer Letters
  17. Vasohibin-2-Targeting Therapies for the Treatment of Pancreatic Ductal Adenocarcinoma
    Yasuhiro Suzuki, Yasufumi Sato · 2024 · The Tohoku Journal of Experimental Medicine
  18. UPF1 deficiency enhances mitochondrial ROS which promotes an immunosuppressive microenvironment in pancreatic ductal adenocarcinoma
    Wenjuan Su, Juan Andres Kochen Rossi, Cristina Nuevo‐Tapioles, Ting Chen, Emily A. Kawaler, Cristina M. Branco, Kwok‐Kin Wong, Diane M. Simeone, Lawrence B. Gardner, Mark R. Philips · 2024 · Proceedings of the National Academy of Sciences
  19. Antitumor potentials of onco-microbial in Chinese patients with pancreatic cancer
    Yongchao Gao, Dingding Zhou, Yebin Lu, Li Yang, Xue-Jun Gong, Man‐Yun Chen, Shuai Liang, Weihua Huang, Wei Zhang · 2024 · Heliyon
  20. A triple-mode strategy on JQ1-loaded nanoplatform for superior antitumor therapy in pancreatic cancer
    Zhiguo Li, Jinxin Duan, Zhiwen Liu, Wei Li, Yiyin Mai, Hao Fu, Guotao Yuan, Jiawei Wang · 2025 · Materials Today Bio
  21. Oncogenic small extracellular vesicles enriched in sphingosine-1-phosphate play a crucial role in pancreatic cancer progression
    Pratibha Malhotra, Jordan Fyfe, Aikaterini Emmanouilidi, Ilaria Casari, Natalie A. Mellett, Kevin Huynh, Marina Pajic, David W. Greening, Peter J. Meikle, Marco Falasca · 2025 · Cellular Signalling
  22. METTL3/IGF2BP3 mediates ORC6 via N6-methyladenosine modification to promote the progression of pancreatic ductal adenocarcinoma
    Yang Shi, Junwei Liu, Qian Cheng, Shengyu Wu, Wenjing Song, Kunlei Wang, Zhi‐Nan Chen, Xinyin Li, Qifeng Wei, Dilinigeer Tayier et al. · 2025 · Gene
  23. Cytotoxic crinane alkaloids of the Amaryllidaceae: in vitro, in vivo and in silico effects, structure–activity relationships and mechanisms of action
    Jerald J. Nair, Johannes Van Staden · 2025 · Phytochemistry Reviews
  24. Metabolic and proteomic signatures differentiate inflammatory phenotypes from cancer and predict treatment response in patient sera
    Gabriel Cutshaw, Elena V. Demidova, Philip Czyzewicz, Elizabeth Quam, Nicole Lorang, AL Warith AL Siyabi, Surinder K. Batra, Sanjeevani Arora, Rizia Bardhan · 2025 · Bioengineering & Translational Medicine
  25. Enhanced anti-cancer effect of AMTB hydrochloride via chitosan nanoparticles in pancreatic cancer
    Jiefeng Liu, Yujing Gong, Xinyu Zeng, Miao He, Bin He, Wenbin Gao, Yong Ming Gao · 2025 · BMC Cancer
  26. Evaluation of the Cytotoxicity and Molecular Docking Properties of the Green Synthesis of Ag2S Nanoparticles
    Emine Yılmaz Arslan, Büşra Özçay Ekşi, Erman Salih Istıflı, Keziban Atacan, Salih Zeki Baş, Mustafa Özmen · 2025 · Journal of Cluster Science
  27. Neoadjuvant Therapy or Upfront Surgery for Pancreatic Cancer—To Whom, When, and How?
    Daria Kwaśniewska, Marta Magdalena Fudalej, Anna Maria Badowska-Kozakiewicz, Aleksandra Izabela Czerw, Andrzej Deptała · 2025 · Cancers
  28. Functional tumor-reactive CD8 + T cells in pancreatic cancer
    Hongwei Sun, Changying Shi, Guoqing Fang, Qiufang Guo, Zhengliang Du, Geer Chen, Yasong Wu, Zhe‐Sheng Chen, Jian Hua, Yan Zhang et al. · 2025 · Journal of Experimental & Clinical Cancer Research
  29. Aryl Hydrocarbon Receptor Ligands Drive Pancreatic Cancer Initiation and Progression through Protumorigenic T-cell Polarization
    Brian D. Griffith, Padma Kadiyala, Jake J. McGue, Lei Sun, Aadith Kumar, Carlos E. Espinoza, Katelyn L. Donahue, Matthew K. Iyer, Cameron B. Speyer, Sarah Nelson et al. · 2025 · Cancer Discovery
  30. DNA Damage and Repair in Pancreatic Cancer—The Latest Findings
    Małgorzata Kozłowska, Michał Mik, Michal O. Nowicki, Agnieszka Śliwińska · 2025 · International Journal of Molecular Sciences
  31. Suppression of pancreatic cancer proliferation through TXNIP-mediated inhibition of the MAPK signaling pathway
    Qinglin Fei, Kaizhou Jin, Saimeng Shi, Tianjiao Li, Duancheng Guo, Meng-Xiong Lin, Xianjun Yu, Weiding Wu, Long‐Yun Ye · 2024 · Acta Biochimica et Biophysica Sinica
  32. TRPA1 Contributes to FGFR2c Signaling and to Its Oncogenic Outcomes in Pancreatic Ductal Adenocarcinoma-Derived Cell Lines
    Vanessa Mancini, Salvatore Raffa, Alessandra Fiorio, Deborah French, Maria Rosaria Torrisi, Danilo Ranieri, Francesca Belleudi · 2024 · Cancers
  33. Modelling the micro- and macro- environment of pancreatic cancer: from patients to pre-clinical models and back
    Eloise G. Lloyd, Joaquín Araos Henríquez, Giulia Biffi · 2024 · Disease Models & Mechanisms
  34. Synthesis of novel triazole-urea hybrids and their antiproliferative activity against pancreatic cancer through suppression of eEF2K and induction of apoptosis
    Aslı Türe, Burcu Özdemir, Onur Çeçe, Güliz Armağan, Mümin Alper Erdoğan, Ömer Erdoğan, Özge Dağdeviren Çevik, İlkay Küçükgüzel · 2024 · Journal of Molecular Structure
  35. Tumor cell-intrinsic epigenetic SETpoint of cancer-associated fibroblasts
    Xiongfeng Chen, Huocong Huang · 2024 · Cancer Cell
  36. Inhibition of DEF‐p65 Interactions as a Potential Avenue to Suppress Tumor Growth in Pancreatic Cancer
    Sicong Huang, Jiaqi Yang, Teng Xie, Yangwei Jiang, Yifan Hong, Xinyuan Liu, Xuyan He, Damiano Buratto, Dong Zhang, Ruhong Zhou et al. · 2024 · Advanced Science
  37. Genetically predicted blood metabolites mediate the association between circulating immune cells and pancreatic cancer: A Mendelian randomization study
    Guo Zhao, Yuanting Cai, Yuning Wang, Yuan Fang, Shuhang Wang, Ning Li · 2024 · The Journal of Gene Medicine
  38. CircRNAs in Pancreatic Cancer: New Tools for Target Identification and Therapeutic Intervention
    Ulrich H. Weidle, Adam Nopora · 2024 · Cancer Genomics & Proteomics
  39. Prognostic and therapeutic value of the Eph/Ephrin signaling pathway in pancreatic cancer explored based on bioinformatics
    Jifeng Liu, Qihang Yuan, Xu Chen, Yao Yang, Tong Xie, Yunshu Zhang, Bing Qi, Shuang Li, Dong Shang · 2024 · Scientific Reports
  40. DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family
    Shaohan Wu, Xiaofang Sun, Ruheng Hua, Chundong Hu, Lei Qin · 2024 · Discover Oncology
  41. Turning to immunosuppressive tumors: Deciphering the immunosenescence-related microenvironment and prognostic characteristics in pancreatic cancer, in which GLUT1 contributes to gemcitabine resistance
    Si-Yuan Lu, Qiong‐Cong Xu, De-Liang Fang, Yin-Hao Shi, Ying‐Qin Zhu, Zhide Liu, Mingjian Ma, Jing‐Yuan Ye, Xiao Yu Yin · 2024 · Heliyon
  42. 19Fluorine ‐ MRI Based Longitudinal Immuno‐Microenvironment‐Monitoring for Pancreatic Cancer
    Wilfried Reichardt, Tabea Gewalt, Philipp Hafner, Steffen J. Keller, Xun Chen, Asma Y. Alrawashdeh, Yayu Li, Solène Besson, Stefan Fichtner‐Feigl, Dominik von Elverfeldt et al. · 2024 · Journal of Magnetic Resonance Imaging
  43. Darifenacin: a promising chitinase 3-like 1 inhibitor to tackle drug resistance in pancreatic ductal adenocarcinoma
    Sofia Martins Sousa, Helena Branco, Amir Avan, Andreia Palmeira, Luca Morelli, Lúcio Lara Santos, Elisa Giovannetti, M. Helena Vasconcelos, Cristina P. R. Xavier · 2024 · Cancer Chemotherapy and Pharmacology
  44. Identification of Gαi3 as a promising molecular oncotarget of pancreatic cancer
    Jian-Zhuo Jiang, Yin-biao Qiao, Xiaoren Zhu, Qian-Hui Gu, Jingjing Lu, Zhenyu Ye, Xu Chun Lü, Yuan-yuan Liu · 2024 · Cell Death and Disease
  45. GL-V9 Promotes Autophagy-Mediated YAP1 Degradation and Activates Mitochondrial Apoptosis in PDAC Cells
    Hao Liu, Zhangxing Lin, Yongjian Guo, Yuxin Zhou, Wei Li · 2024 · Pharmaceuticals
  46. A single-cell perspective on immunotherapy for pancreatic cancer: from microenvironment analysis to therapeutic strategy innovation
    Rui Wang, Jie Liu, Bo Jiang, Benjian Gao, Honghao Luo, Fengyi Yang, Yiqi Ye, Zhuo Chen, Hong Shi Liu, Cheng Cui et al. · 2024 · Frontiers in Immunology
  47. NOP10 predicts poor prognosis and promotes pancreatic cancer progression
    Jin Dou, Weikang Hu, Xiaoyu Zhang, Kuirong Jiang · 2024 · BMC Cancer
  48. Small molecules enhance the high-efficiency generation of pancreatic ductal organoids
    Yuwei Liao, Zhifan Lin, Siyu Li, Xiaolei Yin · 2024 · Acta Biochimica et Biophysica Sinica
  49. Improving predictive accuracy of early recurrence in pancreatic ductal adenocarcinoma: Role of postoperative serum tumor markers
    Arunkumar Krishnan, Declan Walsh · 2024 · World Journal of Gastrointestinal Surgery
  50. Machine learning based identification of an amino acid metabolism related signature for predicting prognosis and immune microenvironment in pancreatic cancer
    Xiaohong Liu, Xing Wang, Jie Ren, Yuan Fang, Minzhi Gu, Feihan Zhou, Ruiling Xiao, Xiyuan Luo, Jialu Bai, Decheng Jiang et al. · 2025 · BMC Cancer
  51. OSBPL3 modulates the immunosuppressive microenvironment and predicts therapeutic outcomes in pancreatic cancer
    Qihui Sun, Xiaoqi Zhu, Qi Zou, Yang Chen, Tingting Wen, Tingting Jiang, Xiaojia Li, Wei Fang, Keping Xie, Jia Liu · 2025 · Biology Direct
  52. HACD2 Promotes Pancreatic Cancer Progression by Enhancing PKM2 Dissociation From PRKN in a Dehydratase‐Independent Manner
    Xuanning Chu, Jinyu Zhao, Yuting Shen, Qi Feng, Changlin Zhou, Lingman Ma, Yu Zhou · 2025 · Advanced Science
  53. Vitamin K‐dependent gamma‐carboxyglutamic acid protein 1 promotes pancreatic ductal adenocarcinoma progression through stabilizing oncoprotein KRAS and tyrosine kinase receptor EGFR
    Zheng Wu, Qing Ye, Shan Zhang, Longgang Hu, Xiao‐Qi Wang, Linli Yao, Lei Zhu, Shu‐Yu Xiao, Zong‐Hao Duan, Xueli Zhang et al. · 2025 · Clinical and Translational Medicine
  54. Risk comparison of adverse reactions between gemcitabine monotherapy and gemcitabine combined with albumin-bound paclitaxel in pancreatic cancer: insights from the FDA Adverse Event Reporting System (FAERS) database
    Puen Jiang, Kezhen Zong, Dadi Peng, Baoyong Zhou, Zhongjun Wu · 2025 · BMC Pharmacology and Toxicology
  55. Tumor-educated platelet, a potential liquid biopsy biosource in pancreatic cancer: A review
    Majid Zaki‐Dizaji, Zahra Taheri, Mohammad Heiat, Kiavash Hushmandi · 2025 · Pathology - Research and Practice
  56. Cytotoxic lycorine alkaloids of the plant family Amaryllidaceae
    Jerald J. Nair, Johannes Van Staden · 2025 · Bioorganic Chemistry
  57. Stromal Hedgehog Signaling Is Associated with Favorable Outcomes in Pancreatic Cancer
    Paul Manoukian, Helene Damhofer, Lan Zhao, Hanneke W.M. van Laarhoven, Maarten F. Bijlsma · 2025 · International Journal of Molecular Sciences
  58. Differential Sensitivity to Ionizing Radiation in Gemcitabine-Resistant and Paclitaxel-Resistant Pancreatic Cancer Cells
    Pei Pei, Alessandro Gregori, Cecilia Bergonzini, Mahsoem Ali, Giulia Mantini, Thomas Schmidt, Francesco Finamore, Stephanie M. Fraga Rodrigues, Adam Enver Frampton, Liam Andrew McDonnell et al. · 2023 · International Journal of Radiation Oncology*Biology*Physics
  59. A benzochalcone derivative synchronously induces apoptosis and ferroptosis in pancreatic cancer cells
    Xiaoqing Guan, Bing Zhao, Xiaodan Guan, Jinyun Dong, Jieer Ying · 2023 · PeerJ
  60. Clinical genomic profiling of malignant giant cell tumor of bone: A retrospective analysis using a real‑world database
    Yusuke Tsuda, Koichi Okajima, Yuki Ishibashi, Liuzhe Zhang, Toshihide Hirai, Hidenori Kage, Aya Shinozaki‐Ushiku, Katsutoshi Oda, Sakae Tanaka, Hiroshi Kobayashi · 2024 · Medicine International
  61. Clinical significance of germline breast cancer susceptibility gene (gBRCA) testing and olaparib as maintenance therapy for patients with pancreatic cancer
    Yasuharu Kawamoto, Takuo Yamai, Kenji Ikezawa, Yusuke Seiki, Ko Watsuji, Takeru Hirao, Makiko Urabe, Yugo Kai, Ryoji Takada, Kaori Mukai et al. · 2024 · BMC Cancer
  62. Copper-KRAS-COX2 Axis: A Therapeutic Vulnerability in Pancreatic Cancer
    Joyeeta Roy, Rima Mouawad, Armita Kyani, Maha Hanafi, Yibin Xu, Bo Wen, Duxin Sun, Nouri Neamati · 2025 · Journal of Medicinal Chemistry
  63. Phase 1/2 study of liposomal irinotecan plus S-1 for metastatic pancreatic cancer refractory to gemcitabine-based treatment
    Hiroshi Imaoka, Masafumi Ikeda, Masato Ozaka, Kotoe Oshima, Naohiro Okano, Satoshi Shimizu, Hidetaka Tsumura, Yoshito Komatsu, Taro Yamashita, Shigeki Kataoka et al. · 2025 · European Journal of Cancer
  64. Identification of novel plasma proteins as promising noninvasive biomarker for early diagnosis and surveillance of pancreatic ductal adenocarcinoma
    Shuang Liu, Jiachun Su, Hongzhe Zhao, Ruihong Bai, Lingxing Zeng, Chunling Xue, Shuang Deng, Shaoqiu Liu, Ziming Chen, Zilan Xu et al. · 2025 · Journal of Gastroenterology
  65. Spatiotemporal Blockade of Autophagy and Macropinocytosis in Pancreatic Cancer via Lysosomal‐Activated Nanoreactors
    Yishi Lu, Ziyue Zu, Nan Zhong, Yang Li, Xuan Sha, Sheng-Feng Lu, Jie Zhang, Hanyao Sun, Xi Luo, Ziqing Xu et al. · 2025 · Advanced Functional Materials
  66. Antioxidant capacity of the iron–sulfur cluster assembly protein IscU2 is mediated by aspartate metabolism to promote tumor survival
    Xunjun Yang, Na Liang, Dandan Liu, Jimei Yan, Xiali Yang, Jinya Lv, Saijun Xiao, Xiujuan Wei, Xuyang Chen, Zhengquan Yang et al. · 2025 · Journal of Biological Chemistry
  67. Phosphatidylcholine Chain-Length of Bioinspired Lipoprotein Modulates Interactions with Collagen for Intratumor Delivery in Pancreatic Cancer
    Guodong Li, Yichen Zhang, Jinhua Wang, Yiyu Liang, Yuan Zhang, Yifei Chi, Carter Sun, Zixin Hu, Shiyang Wu, Guo‐Liang Lu et al. · 2025 · ACS Nano
  68. Serum-Based Detection of Pancreatic and Ovarian Cancer via a Nanoparticle-Enhanced Fluorescence Array and Machine Learning
    Violeta Morcuende-Ventura, Oscar Sanchez‐Gracia, Natalia Abian-Franco, Isabel Jiménez‐Pardo, Lucía Herrer, Martín Castillo‐Vallés, Alexandre Lancelot, F. Javier Falcó-Martí, Sonia Hermoso‐Durán, Roberto Pazo-Cid et al. · 2025 · Analytical Chemistry
  69. The ACSS2-PPARD-BCAT1 axis synchronously regulates branched-chain amino acid metabolism and development in pancreatic cancer
    Haidi Chen, Ye Zeng, Lijun Liu, Wenyan Xu, Yihua Shi, Shunrong Ji, Xiaowu Xu, Xianjun Yu, Sen Hou, Yi Qin et al. · 2025 · Acta Biochimica et Biophysica Sinica
  70. OFD1 inhibition induces BRCAness to create a therapeutic vulnerability to PARP inhibition in pancreatic cancer
    Peng Li, Junjie Ye, Qian Yang, Ni Wang, Chaoyi Li, Xiaoxiao Zou, Han-Yan Luo, Yi Pan, Lingxi Jiang, Baiyong Shen et al. · 2025 · Nature Communications
  71. Cannabidiol Is Associated with Improved Survival in Pancreatic Cancer and Modulation of Bile Acids and Gut Microbiota
    Pratibha Malhotra, Ranjith Palanisamy, Arunima Panda, Ilaria Casari, Janina E. E. Tirnitz‐Parker, Fergal O’Gara, Robert D. Trengove, Krish Ragunath, Jose Antonio Caparros-Martin, Marco Falasca · 2025 · International Journal of Molecular Sciences
  72. Hypoxia promotes pancreatic adenocarcinoma progression by stabilizing ID1 via TRIM21 suppression
    Rui Cheng, Yuanjun Tang, Xuedi Cao, Zhanya Huang, Yunyun Guo, Renjing Jin, Yan Wang, Yang Liu, Lixiang Xue, Yuqing Wang · 2025 · Frontiers in Oncology
  73. Costs of First-Line Treatment With FOLFIRINOX, Modified FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel in Metastatic Pancreatic Ductal Adenocarcinoma
    Syvart Dennen, Marty Masek, Paul C. Cockrum, Elizabeth Nagelhout, Ravi Paler · 2025 · Journal of health economics and outcomes research
  74. Targeting annexin A2 enhances anti-PD-1 immunotherapy in pancreatic ductal adenocarcinoma by remodeling the tumor immune microenvironment
    Mengmeng Liu, Ganggang Wang, Jiameng Gao, Maozhen Peng, Haokang Feng, Xin Liang, Kai Ding, Yu Chen, Chao Song · 2025 · International Immunopharmacology
  75. Mouse pancreatic tumor organoids reveal synergistic efficacy of low-dose anticancer drug and radiation combinations
    Zachery Keepers, Aniketh Sharma, Sanjit Kumer Roy, Hurley Ryan, Binny Bhandary, Lei Ren, Narottam Lamichhane, Hem Dutt Shukla · 2025 · Frontiers in Medicine
  76. The Prolyl Isomerase PIN1 Affects Fibroblast Differentiation States and Cross-talk in Pancreatic Cancer
    Chloe L. Bowman, Colin J. Daniel, Eric J. Carlson, Vidhi M. Shah, Amy S. Farrell, Kayleigh M. Kresse, Xiaoyan Wang, Kyra A. Lindley, Madeline R. Kuhn, Kevin Hawthorne et al. · 2025 · Cancer Research
  77. Daurisoline inhibits pancreatic cancer progression by direct binding to PPARα and blocking its ubiquitination-mediated degradation
    Dongchao Xu, Yuanling Zhu, Wuhan Ye, Yuhua Yu, Xuehui Wang, Chenshan Xu, Ke Jiang, Wangyang Chen, Xiaofeng Zhang, Hongzhang Shen · 2025 · Phytomedicine
  78. Salecan Suppresses Pancreatic Cancer Progression by Promoting Necroptosis via the RIPK1/MLKL Pathway
    Wenya Du, Rong Xu, Pengfei Chen, Jianxia Wen, Luchuanyang Sun, Xianggui Chen · 2025 · Nutrients
  79. Integrative Analysis of TLS‐Associated Gene Signatures, Immune Infiltration and Drug Sensitivity in Pancreatic Cancer
    Mengzhou Gao, Guohui Li, Xin Wang, Xueyun Wang, Danning Tang, Xiang Ao, An Luo, Zhenguo Wen, Teng Wang, Zhaojun Jia · 2025 · IET Systems Biology
  80. Ultrasound‐Triggered Release of Anticancer Nanoparticles from Electrospun Fabrics Integrated with Soft Robotic Tentacles
    Samuel C. T. Moorcroft, Benjamin Calmé, Charles Brooker, Pietro Valdastri, Russell A. Harris, Stephen J. Russell, Giuseppe Tronci · 2025 · Advanced NanoBiomed Research
  81. Loss of TRPV4 reduces pancreatic cancer growth and metastasis
    Joelle M.-J. Romac, Sandip Madhusudan Swain, Nidula Mullappilly, Bandana Bindhani, Rodger A. Liddle · 2025 · JCI Insight
  82. Single-Stranded RNA Origami Remodels Macrophage to Promote the Synergistic Antitumor Effect with 5-Fluorouracil in Pancreatic Cancer
    Xinyi Tu, Yu Lu, Lanshen Zhao, Xiaodong Qi, Yang Y. Xu, Hao Yan · 2025 · JACS Au
  83. Estrogen Production in Pancreatic Cancer Shapes a Tumor-Suppressive Stromal Microenvironment
    Paul Manoukian, Deni M. van Schie, Anne‐Sophie van Schelt, Nienke Petronella Maria Wassenaar, Mark P.G. Dings, Marjolein F. Lansbergen, Cynthia Waasdorp, Rodrigo Leite de Oliveira, Wjera V. Wickenhagen, Annemieke C. Heijboer et al. · 2025 · Cancer Research
  84. Molecular pathology of intraductal papillary mucinous neoplasms of the pancreas: current understanding and perspectives on malignant progression
    Yuki Makino, Kohki Oyama, Akiko Sagara, Fredrik I. Thege, Anirban Maitra · 2025 · Journal of Gastroenterology
  85. Olaparib has synergistic effects with DNA damaging agents in pancreatic ductal adenocarcinoma
    Bahareh Hassani, Amirsajad Jafari, Marjan Tavakkoli, Fatemeh Moosavi, Omidreza Firuzi · 2025 · Biochemical and Biophysical Research Communications
  86. Roles and therapeutic targeting of SLC transporters in gastrointestinal malignancies
    Junshu Wang, Xiaoyu Huang, Shuyi Chen, Yuanci Zhang, Ge Miao, Shuya Du, Xin Wang, Yuanyuan Lu, Xiaodi Zhao · 2025 · Cancer Letters
  87. Cross-platform comparison of gene expression-based cancer molecular subtyping reveals discrepancies with exome capture methods
    Jaewon James Lee, Mohammed Aldakkak, Ashley B. Morrison, Sam Z. Thalji, Xianlu L. Peng, Yan Li, Margaret L. Gulley, Erkut Hasan Borazanci, Susan Tsai, Naim U. Rashid et al. · 2025 · npj Precision Oncology
  88. Preclinical evaluation of CAR-T cell immunotherapy with a fully human EpCAM-specific scFv against pancreatic cancer
    Ying-Ying Fan, Ya-Ling Liu, Xiao-Fan Liu, Si-Qi Jiang, Hui Yang, Hao-Ran Zhang, Ping Wei, Qian-Rong Huang · 2025 · Cancer Immunology Immunotherapy
  89. Matrix stiffness induces Ca2+-DCLK1-PIP5K1A mechanotransduction as a context-specific amplifier in pancreatic cancer progression and chemotherapy resistance
    Haoxiang Zhang, Chuanbing Zhao, Jiaoshun Chen, Xiaoqing Hu, Jianwei Bai, Long He, Zanglong Deng, Tao Yin · 2026 · Experimental Hematology and Oncology
  90. Emerging roles of non-coding RNAs in the tumor microenvironment of pancreatic cancer: Focusing on current challenges and future directions
    Xiao-Tong Cui, Chang-lei Li, Xue Zhong, Yu-Kun Liu, Shi-Guo Liu, Zusen Wang · 2026 · Gene
  91. MIF-CD74 axis facilitates MDSC infiltration in the tumor microenvironment of pancreatic ductal adenocarcinoma
    Hironori Fukuda, Kosuke Arai, Eri Hashimoto, Keisuke Sekine, Yasuhito Arai, Nobuyoshi Hiraoka, Aya Hirata, Makiko Yamashita, Kenta Narumi, Ayaka Kikuchi et al. · 2026 · Cancer Letters
  92. Pilot study of screening method for pancreatic cancer using lipidomic profiling of plasma or serum
    Ondřej Peterka, Robert Jirásko, Zuzana Dolečková, M Dosoudilová, Josef Bártl, Jakub Idkowiak, Ondřej Slavíček, Karolína Pešková, Milan Vošmik, Beatrice Mohelníková-Duchoňová et al. · 2026 · Communications Medicine
  93. Immunoinformatic insights for design and clinical prospects of pan-RAS cancer vaccine
    Ruby Srivastava, Thakur Rochak Kumar Rana · 2026 · Frontiers in Medicine
  94. Ganglioside-Mediated Neural-Acinar Crosstalk Facilitates Pancreatic Carcinogenesis via Metaplastic Niche Remodeling
    Fang Wei, Qi Zou, Jianhong An, Tong Zhang, Qihui Sun, Xiaojia Li, Tingting Jiang, Xiaoqi Zhu, Tingting Wen, Jie He et al. · 2026 · Gastroenterology
  95. Epigenetic dysregulation and microenvironment remodeling in pancreatic cancer
    Ningning Niu, Mo Chen, Jing Xue · 2026 · Trends in cancer
  96. Cancer cell-derived sialylated IgG interacting with Siglec-7/9/10 is a potential immunotherapeutic target in pancreatic cancer
    Shenghua Zhang, Ming Cui, Xinmei Huang, Xiaoyao Feng, Ruiling Xiao, Qijia Liu, Jialu Bai, Xianlin Han, Xiaoding Liu, Weiyan Xu et al. · 2026 · Cell Reports Medicine
  97. Epigenetic and transcriptional control of classical and basal-like cell states in pancreatic ductal adenocarcinoma
    Christina Parassiadis, Steven A. Johnsen · 2026 · Gastroenterology report
  98. The RASSF1C-HIF-1α axis drives macrophage lipid metabolism to promote pancreatic cancer
    Ting Zhan, Min Huang, Mengge Chen, W X Chen, Yiyun Wang, Xiaoli Chen, Yanli Zou, Meng Liu, Qingxi Zhu, Xia Tian et al. · 2026 · Cell Death and Disease
  99. Expression of Claudin-18.2 in pancreatic ductal adenocarcinoma: a systematic review and meta-analysis
    Mohammed Al Subhi, Deema Al-Nabhani, Maryam Al Sarmi, Ahmed Abd Elrahman, Yaqoob Al-Sawafi, Srinivasa Rao Sirasanagandla, Younis Al-Mufargi · 2026 · Frontiers in Medicine
  100. ATM Deficiency Induces TGFβ-Mediated Stromal Programming in Pancreatic Cancer
    Élodie Roger, Hannah M Mummey, Eleni Zimmer, Dharini Srinivasan, Anna Härle, Loïc Moubri, Alica K. Michels, Rima Singh, Menar Ekizce, Michael K. Melzer et al. · 2026 · Cancer Research